1. Home
  2. TPCS vs CELU Comparison

TPCS vs CELU Comparison

Compare TPCS & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • CELU
  • Stock Information
  • Founded
  • TPCS 1956
  • CELU 2016
  • Country
  • TPCS United States
  • CELU United States
  • Employees
  • TPCS N/A
  • CELU N/A
  • Industry
  • TPCS Metal Fabrications
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • CELU Health Care
  • Exchange
  • TPCS Nasdaq
  • CELU Nasdaq
  • Market Cap
  • TPCS 42.6M
  • CELU 42.2M
  • IPO Year
  • TPCS N/A
  • CELU N/A
  • Fundamental
  • Price
  • TPCS $3.74
  • CELU $2.14
  • Analyst Decision
  • TPCS
  • CELU
  • Analyst Count
  • TPCS 0
  • CELU 0
  • Target Price
  • TPCS N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • TPCS 29.5K
  • CELU 66.4K
  • Earning Date
  • TPCS 04-08-2025
  • CELU 05-08-2025
  • Dividend Yield
  • TPCS N/A
  • CELU N/A
  • EPS Growth
  • TPCS N/A
  • CELU N/A
  • EPS
  • TPCS N/A
  • CELU N/A
  • Revenue
  • TPCS $33,154,058.00
  • CELU $54,220,000.00
  • Revenue This Year
  • TPCS N/A
  • CELU $23.29
  • Revenue Next Year
  • TPCS N/A
  • CELU N/A
  • P/E Ratio
  • TPCS N/A
  • CELU N/A
  • Revenue Growth
  • TPCS 8.71
  • CELU 138.11
  • 52 Week Low
  • TPCS $2.05
  • CELU $1.00
  • 52 Week High
  • TPCS $4.42
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 54.79
  • CELU 58.35
  • Support Level
  • TPCS $3.45
  • CELU $1.82
  • Resistance Level
  • TPCS $3.85
  • CELU $2.11
  • Average True Range (ATR)
  • TPCS 0.23
  • CELU 0.20
  • MACD
  • TPCS 0.00
  • CELU 0.02
  • Stochastic Oscillator
  • TPCS 62.32
  • CELU 80.23

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: